Article Details
Retrieved on: 2021-08-16 14:05:41
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Second-Generation mRNA COVID-19 Vaccine Candidate, CV2CoV, Demonstrates Improved Immune Response and Protection in Preclinical Study.
Article found on: www.curevac.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here